These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 23637955

  • 1. Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.
    Zhang C, Li C, Zhu M, Zhang Q, Xie Z, Niu G, Song X, Jin L, Li G, Zheng H.
    PLoS One; 2013; 8(4):e62023. PubMed ID: 23637955
    [Abstract] [Full Text] [Related]

  • 2. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
    Hu C, Wang J, Xu Y, Li X, Chen H, Bunjhoo H, Xiong W, Xu Y, Zhao J.
    Gene; 2013 Mar 15; 517(1):65-71. PubMed ID: 23313298
    [Abstract] [Full Text] [Related]

  • 3. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
    Saracini C, Bolli P, Sticchi E, Pratesi G, Pulli R, Sofi F, Pratesi C, Gensini GF, Abbate R, Giusti B.
    J Vasc Surg; 2012 Jan 15; 55(1):171-179.e2. PubMed ID: 22094117
    [Abstract] [Full Text] [Related]

  • 4. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
    Pereza N, Ostojić S, Volk M, Kapović M, Peterlin B.
    Reprod Biomed Online; 2012 May 15; 24(5):567-75. PubMed ID: 22406112
    [Abstract] [Full Text] [Related]

  • 5. Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis.
    Liu D, Guo H, Li Y, Xu X, Yang K, Bai Y.
    PLoS One; 2012 May 15; 7(2):e31251. PubMed ID: 22348060
    [Abstract] [Full Text] [Related]

  • 6. Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival.
    González-Arriaga P, Pascual T, García-Alvarez A, Fernández-Somoano A, López-Cima MF, Tardón A.
    BMC Cancer; 2012 Mar 28; 12():121. PubMed ID: 22455335
    [Abstract] [Full Text] [Related]

  • 7. Association of MMP2 and MMP9 gene polymorphisms with the recurrent spontaneous abortion: A meta-analysis.
    Yan Y, Fang L, Li Y, Yu Y, Li Y, Cheng JC, Sun YP.
    Gene; 2021 Jan 30; 767():145173. PubMed ID: 33007375
    [Abstract] [Full Text] [Related]

  • 8. Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer.
    Liu D, Duan W, Guo H, Xu X, Bai Y.
    Int J Colorectal Dis; 2011 Sep 30; 26(9):1099-105. PubMed ID: 21538057
    [Abstract] [Full Text] [Related]

  • 9. [Associating of polymorphism in the promoter regions of genes of metalloproteinase (MMP2, MMP3, MMP9) with options of the clinical course of breast cancer in Russian women].
    Shevchenko AV, Konenkov VI, Garbukov EIu, Stakheeva MN.
    Vopr Onkol; 2014 Sep 30; 60(5):630-5. PubMed ID: 25816670
    [Abstract] [Full Text] [Related]

  • 10. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.
    Peng B, Cao L, Wang W, Xian L, Jiang D, Zhao J, Zhang Z, Wang X, Yu L.
    Mutagenesis; 2010 Jan 30; 25(1):41-8. PubMed ID: 19843588
    [Abstract] [Full Text] [Related]

  • 11. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
    Padala C, Tupurani MA, Puranam K, Gantala S, Shyamala N, Kondapalli MS, Gundapaneni KK, Mudigonda S, Galimudi RK, Kupsal K, Nanchari SR, Chavan U, Chinta SK, Mukta S, Satti V, Hanumanth SR.
    PLoS One; 2017 Jan 30; 12(9):e0184448. PubMed ID: 28961241
    [Abstract] [Full Text] [Related]

  • 12. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
    Zinzindohoué F, Blons H, Hans S, Loriot MA, Houllier AM, Brasnu D, Laccourreye O, Tregouet DA, Stucker I, Laurent-Puig P.
    Anticancer Res; 2004 Jan 30; 24(3b):2021-6. PubMed ID: 15274394
    [Abstract] [Full Text] [Related]

  • 13. Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population.
    Xu X, Wang L, Xu C, Zhang P, Yong F, Liu H, Wang J, Shi Y.
    Coron Artery Dis; 2013 Jun 30; 24(4):259-65. PubMed ID: 23377317
    [Abstract] [Full Text] [Related]

  • 14. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.
    Peng B, Cao L, Ma X, Wang W, Wang D, Yu L.
    Mutagenesis; 2010 Jul 30; 25(4):371-9. PubMed ID: 20360147
    [Abstract] [Full Text] [Related]

  • 15. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients.
    Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Reznakova V, Kralova M, Hromadka T, Shawkatova I.
    Mediators Inflamm; 2021 Jul 30; 2021():5573642. PubMed ID: 33986628
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer.
    Zhang L, Xi RX, Zhang XZ.
    Genet Mol Res; 2015 May 04; 14(2):4616-24. PubMed ID: 25966235
    [Abstract] [Full Text] [Related]

  • 17. Association between MMP1 -1607 1G>2G polymorphism and head and neck cancer risk: a meta-analysis.
    Zhang C, Song X, Zhu M, Shi S, Li M, Jin L, Lang J, Li G, Zheng H.
    PLoS One; 2013 May 04; 8(2):e56294. PubMed ID: 23441173
    [Abstract] [Full Text] [Related]

  • 18. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
    Xia S, Wu S, Wang M.
    Technol Cancer Res Treat; 2021 May 04; 20():15330338211033060. PubMed ID: 34278875
    [Abstract] [Full Text] [Related]

  • 19. Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
    Chaudhary AK, Singh M, Bharti AC, Singh M, Shukla S, Singh AK, Mehrotra R.
    BMC Cancer; 2010 Jul 14; 10():369. PubMed ID: 20630073
    [Abstract] [Full Text] [Related]

  • 20. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
    Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Köppel H, Leithner A, Wascher TC, Paulweber B, Samonigg H.
    Clin Cancer Res; 2004 May 15; 10(10):3518-20. PubMed ID: 15161710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.